Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Large private investment firm, Bain Capital, plans to sell its majority stake in an insurance broker and agency network based ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...

Bain Capital is on the cusp of signing a deal to buy UK broker Jensten from private equity (PE) firm Livingbridge, Insurance ...

The Coldplay kiss cam scandal has sent shockwaves around the world - and brought the two families of the CEO and the HR chief ...

Saint Louis, MO, July 2025 – ButcherJoseph & Co. (“ButcherJoseph”) a boutique investment banking firm specializing in ESOPs and strategic corporate finance solutions, is pleased to welcome Thomas ...

"If we are getting creative, a possible claim would be for defamation," an attorney exclusively tells Page Six.

Building on Waystar's track record of successful M&A execution and synergy realization, Waystar expects the acquisition of Iodine to be immediately accretive to gross margin and adjusted EBITDA margin ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...

We recently compiled a list of 11 Best Undervalued Stocks to Invest in Now. Lincoln National Corporation stands third on our ...

American private investment firm Bain Capital is on the verge of acquiring a significant stake in Manappuram Finance, one of Kerala’s leading gold loan providers, in a deal valued at ...